KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Capital Expenditures (2018 - 2025)

BioNTech SE's Capital Expenditures history spans 8 years, with the latest figure at -$73.6 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 3.37% to -$73.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$197.6 million, a 36.26% increase, with the full-year FY2025 number at -$197.8 million, up 35.38% from a year prior.
  • Capital Expenditures hit -$73.6 million in Q4 2025 for BioNTech SE, down from -$42.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for BNTX hit a ceiling of -$26.18 in Q1 2021 and a floor of -$139.4 million in Q4 2022.
  • Historically, Capital Expenditures has averaged -$65.0 million across 5 years, with a median of -$67.4 million in 2024.
  • Biggest five-year swings in Capital Expenditures: surged 100.0% in 2021 and later crashed 189090564.66% in 2022.
  • Tracing BNTX's Capital Expenditures over 5 years: stood at -$45.1 million in 2021, then tumbled by 209.2% to -$139.4 million in 2022, then soared by 35.3% to -$90.2 million in 2023, then grew by 21.07% to -$71.2 million in 2024, then fell by 3.37% to -$73.6 million in 2025.
  • Business Quant data shows Capital Expenditures for BNTX at -$73.6 million in Q4 2025, -$42.0 million in Q3 2025, and -$30.7 million in Q2 2025.